Generic drug price-fixing suit is akin to earlier case, but ‘on steroids,’ Conn. prosecutor says. (STAT Plus)

More reads

• Generic drug price-fixing suit is akin to earlier case, but ‘on steroids,’ Conn. prosecutor says. (STAT Plus)
• Biotech IPO performance pokes holes in Silicon Valley’s theory for waiting so long to go public. (CNBC)
• Biotech startups and the hard truth of innovation. (Forbes)
• Supreme Court gives Merck a break and orders Fosamax lawsuits to be revisited. (STAT Plus)